First UK patient cohort treated with stereotactic ablative radiotherapy for primary kidney cancer.
Anjali ZarkarDan HendersonAntony CarverGeoff HeyesVictoria HarropSarah TutillJulie KilkennyAndrea MarshallNada ElbeltagiHelen HowardPublished in: BJUI compass (2023)
SABR for primary RCC is a safe and feasible treatment for medically unfit patients, which can be delivered in most UK cancer centres using standard Linear Accelerator as well as CyberKnife platforms.
Keyphrases
- papillary thyroid
- newly diagnosed
- end stage renal disease
- squamous cell
- ejection fraction
- early stage
- chronic kidney disease
- radiation therapy
- prognostic factors
- peritoneal dialysis
- small cell lung cancer
- young adults
- cross sectional
- radiation induced
- lymph node metastasis
- locally advanced
- patient reported outcomes